A sensitive radioimmunoassay measuring serum medroxyprogesterone acetate (MPA) has
been developed in order to measure and correlate serum MPA concentrations and ovarian …

The effects of a single administration of depo-medroxyprogesterone acetate (DMPA) at
different doses upon ovarian function was studied in a group of healthy ovulating Mexican …

A radioimmunoassay (RIA) method for measuring medroxyprogesterone acetate (MPA,
Provera®) in serum has been developed utilizing benzene: isooctane extraction, 3 H-MPA to …

The aim of the study was to evaluate the functional state of the hypothalamo-pituitary-
gonadal axis and to assess the concentrations of MPA in the peripheral blood during very …

A radioimmunoassay for measuring medroxyprogesterone acetate in serum or plasma is
described using an antiserum produced against the steroid-3-carboxymethyloxime coupled …

Depot medroxyprogesterone acetate (DMPA) is an aqueous suspension of 17-acetoxy 6-
methyl progestin administered by intramuscular injection for long-term contraception. This …

APOTENT progestational agent, 6-methyl-17a!-hydroxyprogesterone acetate
(medroxyprogesterone acetate, MPA) suppresses gonadal function in animals (1, 2) and …

The peripheral blood levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH
were measured after an intramuscular injection of 150 mg and 300 mg of Depo-Provera® in …

In an attempt to elucidate the effect of paramethasone acetate on the hormonal profile of the
normal menstrual cycle, 5 clinically healthy women, aged 24–36 yr, with ovulatory cycles …

A double antibody radioimmunoassay is described which is capable of detecting 100 pg of
medroxyprogesterone acetate (Provera) in 0.1 ml of unextracted serum. The antibody was …